Overview The Royal Marsden NHS Foundation Trust is seeking an exceptional and influential Deputy Chief Executive to work closely with the Chief Executive, Executive Team, and Board in delivering several of the Trust’s most ambitious and high impact strategic programmes. This is a rare and exciting opportunity to help shape the future of one of the world’s leading cancer centres. The Deputy Chief Executive will drive transformation, growth and innovation across the organisation, strengthening the ability to deliver outstanding patient care, advance world-class research, and sustain exceptional organisational performance. Responsibilities

Provide senior leadership for significant Trust programmes, including the development of estate and infrastructure and supporting delivery of the Trust’s Clinical and Research Strategies. Play a major role in the forthcoming redevelopment of the Chelsea site and shape the strategic direction and successful delivery of this capital programme. Operate in a complex stakeholder environment with credibility to influence at regional and national levels; build collaborative relationships with partners across the NHS, academia and the commercial sector.

Candidate profile / Qualifications

Strong track record of senior leadership within the healthcare sector, with proven experience of influencing key stakeholders internally and externally. Ability to foster constructive and productive working relationships, with personal gravitas and strong commercial and financial acumen. Outstanding leadership capability in engaging and influencing senior leaders across the organisation.

How to apply Candidates are invited to provide a covering letter detailing their interest and suitability for the role, accompanied by a full and up-to-date CV. For a confidential discussion, please contact: Krystyna Ruszkiewicz, Chief People Officer via Julie.McIlvaney@rmh.nhs.uk. Closing date: 7th April 2026. Interview will be held on 16th April 2026. About The Royal Marsden As one of the leading cancer centres in the world with a track record of developing new and better ways of diagnosing and treating cancer, The Royal Marsden contributes to improved outcomes for patients globally. Its primary aim is to deliver the best cancer treatment through world-leading research, operating a ‘bench to bedside’ strategy with our academic partner, The Institute of Cancer Research (ICR). As a specialist provider, The Royal Marsden has a responsibility to innovate and ensure that it can act as a test bed of best practice for the NHS. The Trust has a history of trialling new technology, from intensity-modulated radiotherapy techniques to installing the UK’s first Magnetic Resonance Linear Accelerator (MR Linac) machine and developing the largest and most comprehensive programme of robotic surgery in the UK. The Trust is also the host and founder of RM Partners, one of 19 cancer alliances made up of healthcare providers along the pathway from primary care to specialist hospital provision. The Royal Marsden and RM Partners are pioneering new models of care, rapidly translating clinical research into clinical practice. Its focus is on transforming early diagnosis to improve cancer survival. #J-18808-Ljbffr